GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Selling and Marketing Expense

AWKNF (Awakn Life Sciences) Selling and Marketing Expense : $0.23 Mil (TTM As of Oct. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Awakn Life Sciences's Selling and Marketing Expense for the three months ended in Oct. 2024 was $0.04 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Oct. 2024 was $0.23 Mil.

Awakn Life Sciences Selling and Marketing Expense Historical Data

The historical data trend for Awakn Life Sciences's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Selling and Marketing Expense Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Selling and Marketing Expense
0.06 1.29 0.87 0.33

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.10 0.06 0.04 0.04

Awakn Life Sciences Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Awakn Life Sciences Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Selling and Marketing Expense
Comparable Companies
TSXV:XRTX TSX:APLI XCNQ:LOBE XCNQ:MBIO XCNQ:ENBI XCNQ:ASEP XCNQ:RIZE XCNQ:MYND TSXV:QPT XCNQ:NIRV VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 ONC
Traded in Other Exchanges
N/A
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Website
https://www.awaknlifesciences.com
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.